Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Amarin Corp ADR
(NQ:
AMRN
)
0.6100
UNCHANGED
Streaming Delayed Price
Updated: 2:30 PM EDT, Sep 5, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Amarin Corp ADR
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Amarin Chairman & CEO Issue Letter to Shareholders
January 22, 2024
From
Amarin Corporation plc
Via
GlobeNewswire
Why TechTarget Shares Are Trading Higher By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
January 11, 2024
Shares of TechTarget, Inc. (NASDAQ: TTGT) rose sharply during Thursday’s session after the company announced a strategic combination with Informa Tech's digital businesses. TechTarget shares surged...
Via
Benzinga
Aspen Aerogels Issues Business Update, Joins Plug Power, SunPower And Other Big Stocks Moving Lower On Thursday
January 11, 2024
U.S. stocks traded lower, with the Dow Jones index falling over 150 points on Thursday. Shares of Aspen Aerogels, Inc. (NYSE: ASPN) fell sharply during Thursday’s session after the company issued a...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Amarin Stock Skyrocketed Today
January 10, 2024
The biopharma company announced a big repurchase plan, along with strong preliminary Q4 results.
Via
The Motley Fool
Why Pharma Company Amarin Shares Are Zooming Today
January 10, 2024
Amarin Corp PLC (NASDAQ: AMRN) shares are trading by around 28% after the company reported
Via
Benzinga
Crude Oil Falls 1%; Amarin Shares Spike Higher
January 10, 2024
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining over 100 points on Wednesday. The Dow traded up 0.29% to 37,633.43 while the NASDAQ rose 0.72% to 14,965.31. The...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
January 10, 2024
Shares of WD-40 Company (NASDAQ: WDFC) rose sharply during Wednesday’s session after the company reported better-than-expected first-quarter results.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
January 10, 2024
Via
Benzinga
What's Going On With Amarin Stock?
January 10, 2024
Amarin Corporation (NASDAQ: AMRN) shares are trading higher Wednesday after the company released a business update and announced a conditional s
Via
Benzinga
Nasdaq Gains 50 Points; US Crude Inventories Rise Last Week
January 10, 2024
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 50 points on Wednesday. The Dow traded up 0.17% to 37,588.15 while the NASDAQ rose 0.34% to 14,908.42. The S&P...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 10, 2024
Via
Benzinga
Amarin Provides Preliminary Fourth Quarter 2023 Selected Financials and Outlines Key Priorities For 2024
January 10, 2024
From
Amarin Corporation plc
Via
GlobeNewswire
Amarin to Present at the 42nd Annual J.P. Morgan Healthcare Conference
December 11, 2023
From
Amarin Corporation plc
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
December 04, 2023
Via
Benzinga
New REDUCE-IT® Analyses Show VASCEPA® (icosapent ethyl) Associated with 29 Percent Relative Risk Reduction Compared with Placebo in Prespecified Subgroup of Patients with Metabolic Syndrome, but Without Diabetes at Baseline
November 12, 2023
From
Amarin Corporation plc
Via
GlobeNewswire
Amarin Plc (AMRN) Q3 2023 Earnings Call Transcript
November 01, 2023
AMRN earnings call for the period ending September 30, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Amarin Reports Third Quarter 2023 Financial Results
November 01, 2023
From
Amarin Corporation plc
Via
GlobeNewswire
Amarin Appoints Jonathan Provoost Executive Vice President, Chief Legal & Compliance Officer
October 31, 2023
From
Amarin Corporation plc
Via
GlobeNewswire
Latest Research Evaluating VASCEPA®/VAZKEPA® (icosapent ethyl) and Subgroups from the REDUCE-IT Landmark Outcomes Trial to be Presented at the American Heart Association (AHA) Scientific Sessions 2023
October 26, 2023
-- Additional Mechanistic Data on Eicosapentaenoic Acid (EPA) and Real-World Characteristics of Patients with Diabetes on IPE Also Featured at the Meeting --
From
Amarin Corporation plc
Via
GlobeNewswire
Alphabet To Rally Over 33%? Here Are 10 Top Analyst Forecasts For Wednesday
October 25, 2023
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page
Via
Benzinga
Amarin to Report Third Quarter 2023 Financial Results and Host Conference Call on November 1, 2023
October 19, 2023
From
Amarin Corporation plc
Via
GlobeNewswire
Amarin to Present at the 2023 Cantor Global Healthcare Conference
September 12, 2023
From
Amarin Corporation plc
Via
GlobeNewswire
Around $15M Bet On Taysha Gene Therapies? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
August 17, 2023
The Dow Jones closed lower by around 180 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Trade Desk, Plug Power, TaskUs And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
August 10, 2023
U.S. stock futures traded higher this morning on Thursday. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Amarin Provides Pricing & Reimbursement Updates for VAZKEPA (icosapent ethyl) in The Netherlands and Italy
August 09, 2023
From
Amarin Corporation plc
Via
GlobeNewswire
Amarin And Neopharm Announce Exclusive Commercialization Agreement for VAZKEPA® (Icosapent Ethyl) in Israel
August 08, 2023
From
Amarin Corporation plc
Via
GlobeNewswire
Scottish Medicines Consortium Accepts VAZKEPA® (icosapent ethyl) to Help Reduce Cardiovascular Risk for Patients in Scotland(1)
August 07, 2023
From
Amarin Corporation plc
Via
GlobeNewswire
Amarin Reports Second Quarter 2023 Financial Results
August 02, 2023
From
Amarin Corporation plc
Via
GlobeNewswire
Amarin and Lotus Pharmaceuticals Announce Exclusive Partnership Agreement to Commercialize Vazkepa® (Icosapent Ethyl) in Southeast Asia and South Korea
July 31, 2023
Collaboration Broadens Reach of VAZKEPA to Additional Ten Countries Leveraging Lotus’ Established Commercial and Marketing Expertise in the Region
From
Amarin Corporation plc
Via
GlobeNewswire
Latest Research Evaluating Clinical Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the European Society of Cardiology (ESC) Congress
July 26, 2023
From
Amarin Corporation plc
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.